Trials / Completed
CompletedNCT06451380
Patient-controlled Sedation With Propofol Versus Anesthesiologist-administered Sedation for Orthopedic Surgery
Patient-controlled Sedation With Propofol Versus Anesthesiologist-administered Sedation for Orthopedic Surgery Under Regional Anesthesia : a Prospective Randomized Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 70 (actual)
- Sponsor
- GCS Ramsay Santé pour l'Enseignement et la Recherche · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to compare patient satisfaction with patient-controlled sedation with propofol and anesthesiologist-controlled sedation during orthopedic procedures of the upper limb under locoregional anesthesia.
Detailed description
This is an interventional, prospective, randomized, open-label, controlled, single-center study designed to evaluate the less commonly used patient-controlled sedation, comparing it with sedation administered by the anesthesiologist in a population of patients indicated for orthopedic upper limb surgery requiring additional sedation. Once informed consent has been signed, patients will be randomized into one of two study arms in a 1:1 ratio, stratified by age: * Experimental arm (1) : patient-controlled propofol sedation ; * Control arm (2) : anesthesiologist-controlled propofol sedation. Patient participation in the study lasts from 1 to 7 days maximum (from preoperative inclusion to hospital discharge).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | orthopaedic surgery | orthopaedic surgery of the upper limb under anaesthesia |
| DRUG | propofol anesthesia | The initial dose of propofol and the refractory period will be determined according to a standardized protocol used in current practice. |
Timeline
- Start date
- 2024-10-02
- Primary completion
- 2025-01-09
- Completion
- 2025-01-09
- First posted
- 2024-06-11
- Last updated
- 2025-11-24
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT06451380. Inclusion in this directory is not an endorsement.